Zhejiang Yatai Pharmaceutical Co., Ltd.

002370.SZ

002370.SZZhejiang Yatai Pharmaceutical Co., Ltd. CN flag

Shenzhen

3.98

CNY

+0.04

(+1.02%)

-0.03EPS

-132.67P/E

2.49BMarket Cap

Apr 18Next Earn

Upgrade to Unlock Non-US CompaniesTo view real-time data and analysis of companies outside of the United States, upgrade your account to our premium subscription.

Upgrade

ISIN

CNE100000MM5

Return %

Stock

S&P500

-12.53

30.48

-3.16

29.20

-41.30

91.72

Use logarithmic scale

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	TTM
Revenue per Share	1.01	0.8	0.86	0.93	1.13	1.73	1.69	2.1	1.32	0.94	0.59	0.7	0.71	0.7
Basic EPS, GAAP	0.11	-0.06	0.01	0.1	0.14	0.22	0.26	0.28	-3.58	0.05	-0.43	-0.25	-0.02	-0.03
Free Cash Flow per Basic Share	0.03	-0.1	0.02	-0.05	0.16	-0.26	-0.29	-1.1	-0.65	-0.04	-0.04	-0.02	0.01	-0.02
Dividend per Share	0.05	0.05	- -	0.01	0.06	0.1	0.05	0.11	0.08	0.03	0.03	0.03	0.03	0.02
Book Value per Share	0.89	0.83	0.91	0.9	0.96	1.22	1.69	1.85	-1.75	-1.67	-2.15	-2.4	-2.04	-1.96
Tangible Book Value per Share	1.73	1.68	1.84	1.7	0.08	3.2	2.84	2.79	0.99	1	0.59	0.42	0.86	0.91
Basic Weighted Avg Shares	417	396	365	406	411	440	537	539	537	545	531	531	594	612
Sales/Revenue/Turnover	420	316	314	376	463	762	907	1,132	709	515	315	373	421	426
Operating Margin (%)	10.13	-9.62	1.46	12.4	13.57	17.82	17.99	17.5	-17	-11.38	-39.02	-2.45	-6.19	-1.6
Depreciation Expense	19	20	24	25	29	39	38	44	53	49	44	42	39	- -
Net Income, GAAP	44	-26	5	41	55	97	140	151	-1,921	27	-228	-133	-12	-17
Effective Tax Rate (%)	13.18	- -	5.51	16.16	14.39	10.5	14.11	12.62	- -	3.95	- -	- -	- -	- -
Profit Margin (%)	10.42	-8.14	1.75	10.8	11.98	12.7	15.38	13.33	-270.79	5.3	-72.44	-35.53	-2.82	-3.9
Working Capital	468	390	400	394	99	947	907	810	1,309	982	782	782	793	218
LT Debt	- -	- -	- -	- -	513	- -	100	165	982	933	863	900	639	- -
Total Equity	745	704	710	747	793	2,166	2,278	2,376	633	660	433	301	581	625
Return on Invested Capital (%)	4.67	- -	0.59	5.26	4.63	6.5	6.14	6.91	- -	-3.34	- -	- -	- -	- -
Return on Capital (%)	12.15	- -	1.74	11.13	7.55	13.68	17.45	13.95	- -	86.7	- -	- -	- -	- -
Return on Common Equity (%)	13.75	-7.35	1.65	11.6	14.58	20.81	19.33	15.85	- -	- -	- -	- -	- -	- -

Capital Structure

•

in mil. unless spec.

Working Capital

•

in mil. unless spec.

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)	10 years	5 years	1 year
Sales/Revenue/Turnover	7.91%	-14.49%	12.64%
Net Income, GAAP	-173.99%	-508.74%	-91.05%
Free Cash Flow	-110.21%	-75.18%	-179.42%
Total Cash Common Dividend	99.63%	-16.42%	18.83%
Total Equity	15.29%	-8.22%	92.81%

Growth Rates

•

in mil. unless spec.

Quarterly Revenue

•

in mil. unless spec.

Quarterly Earnings Per Share

•

in mil. unless spec.

Quarterly Dividends Per Share

•

in mil. unless spec.

Company Description

CEO: Mr. Jianwei Cen
Full Time Employees: 528
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Address: No. 36, Nanbin West Road Shaoxing People's Republic of China 312030
IPO Date: Mar 16, 2010
Website: en.ytyaoye.com
Similar Companies: Shandong Xinhua Pharmaceutical Company Limited (000756.SZ)
Radient Technologies Inc. (RTI.V)
One World Products, Inc. (OWPC)
Cresco Labs Inc. (CRLBF)
MERCK Kommanditgesellschaft auf Aktien (MER.SW)
Procter & Gamble Health Limited (PGHL.NS)
Business: Zhejiang Yatai Pharmaceutical Co., Ltd. researches, produces, sells, and exports pharmaceutical products in China and internationally. It offers tablets, capsules, patches, powder injections, and troches. It also provides chemical agents and raw materials, and diagnostic reagents, as well as pharmaceutical research and development outsourcing services. Zhejiang Yatai Pharmaceutical Co., Ltd. was founded in 1989 and is based in Shaoxing, China.

	Mar'24	Jun'24	Sep'24
Total Current Assets	897	912	905
Accounts Receivable, Net	72	75	80
Cash, Cash Equivalents & STI	663	686	689
Inventories	92	82	69
Total Current Liabilities	101	736	686
Payables & Accruals	- -	- -	- -
ST Debt	- -	646	607
Deferred Revenue	- -	- -	- -

	Mar'24	Jun'24	Sep'24
ST Debt	- -	646	607
LT Borrowings	637	- -	- -
LT Finance Leases	- -	- -	- -
Preferred Equity and Hybrid Capital	- -	- -	- -
Shares Outstanding	609	609	625
Market Capitalization	2,166	1,524	2,007

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	TTM
Revenue per Share	1.01	0.8	0.86	0.93	1.13	1.73	1.69	2.1	1.32	0.94	0.59	0.7	0.71	0.7
Basic EPS, GAAP	0.11	-0.06	0.01	0.1	0.14	0.22	0.26	0.28	-3.58	0.05	-0.43	-0.25	-0.02	-0.03
Free Cash Flow per Basic Share	0.03	-0.1	0.02	-0.05	0.16	-0.26	-0.29	-1.1	-0.65	-0.04	-0.04	-0.02	0.01	-0.02
Dividend per Share	0.05	0.05	- -	0.01	0.06	0.1	0.05	0.11	0.08	0.03	0.03	0.03	0.03	0.02
Book Value per Share	0.89	0.83	0.91	0.9	0.96	1.22	1.69	1.85	-1.75	-1.67	-2.15	-2.4	-2.04	-1.96
Tangible Book Value per Share	1.73	1.68	1.84	1.7	0.08	3.2	2.84	2.79	0.99	1	0.59	0.42	0.86	0.91
Basic Weighted Avg Shares	417	396	365	406	411	440	537	539	537	545	531	531	594	612
Sales/Revenue/Turnover	420	316	314	376	463	762	907	1,132	709	515	315	373	421	426
Operating Margin (%)	10.13	-9.62	1.46	12.4	13.57	17.82	17.99	17.5	-17	-11.38	-39.02	-2.45	-6.19	-1.6
Depreciation Expense	19	20	24	25	29	39	38	44	53	49	44	42	39	- -
Net Income, GAAP	44	-26	5	41	55	97	140	151	-1,921	27	-228	-133	-12	-17
Effective Tax Rate (%)	13.18	- -	5.51	16.16	14.39	10.5	14.11	12.62	- -	3.95	- -	- -	- -	- -
Profit Margin (%)	10.42	-8.14	1.75	10.8	11.98	12.7	15.38	13.33	-270.79	5.3	-72.44	-35.53	-2.82	-3.9
Working Capital	468	390	400	394	99	947	907	810	1,309	982	782	782	793	218
LT Debt	- -	- -	- -	- -	513	- -	100	165	982	933	863	900	639	- -
Total Equity	745	704	710	747	793	2,166	2,278	2,376	633	660	433	301	581	625
Return on Invested Capital (%)	4.67	- -	0.59	5.26	4.63	6.5	6.14	6.91	- -	-3.34	- -	- -	- -	- -
Return on Capital (%)	12.15	- -	1.74	11.13	7.55	13.68	17.45	13.95	- -	86.7	- -	- -	- -	- -
Return on Common Equity (%)	13.75	-7.35	1.65	11.6	14.58	20.81	19.33	15.85	- -	- -	- -	- -	- -	- -

Zhejiang Yatai Pharmaceutical Co., Ltd.

Growth Rates

(avg. rate of change)

Company Description

Growth Rates

(avg. rate of change)

Working Capital

Capital Structure

Quarterly Earnings Per Share

Year

Quarterly Dividends Per Share

Year

Quarterly Revenue

Year

Year	Q1	Q2	Q3	Q4	FY
2022	-0.05	- -	- -	- -	-0.25
2023	- -	- -	- -	- -	-0.02
2024	- -	- -	- -	- -	- -